Skip to main content
Premium Trial:

Request an Annual Quote

Gene Express Joins FDA s Microarray Quality Control Program

NEW YORK, March 2 (GenomeWeb News) - Gene Express will participate in the US Food and Drug Administration's Micro Array Quality Control Consortium, the company said yesterday.

 

Under the agreement, Gene Express will analyze samples with its StaRT-PCR technology.

 

Other members of the consortium include the National Institutes of Health, the National Cancer Institute, the Environmental Protection Agency, the National Institute of Standards and Technology, Affymetrix, GE Healthcare, Applied Biosystems, Agilent, Eppendorf, Genospectra, Illumina, Biogen, and Novartis.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.